Charter Oak Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-458
| Closed | -$34K | – | 908 |
|
|
2022
Q2 | $34K | Sell |
458
-14
| -3% | -$1.04K | ﹤0.01% | 391 |
|
|
2022
Q1 | $42K | Sell |
472
-220
| -32% | -$19.6K | 0.01% | 385 |
|
|
2021
Q4 | $77K | Hold |
692
| – | – | 0.01% | 287 |
|
|
2021
Q3 | $87K | Sell |
692
-6
| -0.9% | -$754 | 0.01% | 265 |
|
|
2021
Q2 | $95K | Buy |
698
+37
| +6% | +$5.04K | 0.01% | 248 |
|
|
2021
Q1 | $90K | Buy |
661
+262
| +66% | +$35.7K | 0.01% | 249 |
|
|
2020
Q4 | $56K | Buy |
+399
| New | +$56K | 0.01% | 282 |
|